SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-007094
Filing Date
2021-06-21
Accepted
2021-06-21 16:58:54
Documents
4
Period of Report
2021-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 33873
2 UNDERWRITING AGREEMENT ndra_ex11.htm EX-1.1 247513
3 OPINION ON LEGALITY ndra_ex51.htm EX-5.1 15279
4 IMAGE ndra.jpg GRAPHIC 2197
  Complete submission text file 0001654954-21-007094.txt   301118
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 211031537
SIC: 3845 Electromedical & Electrotherapeutic Apparatus